Pharmalot… Pharmalittle… Good Morning

Hello, everyone, and nice to see you again. Another long weekend on this side of the pond is now officially over, which means the time has come to resume that daunting routine of meetings and deadlines and what-not. Hopefully, you are all feeling up to the task. In any event, one way to cope is to quaffe a nice cup of stimulation, so go ahead and indulge. Meanwhile, here are some tidbits to help you along. Hope your day goes well and drop us a line if you run across anything interesting. We are up for adventure…
J&J Misses Estimates, May Sell Ortho Diagnostics Unit (Bloomberg News)
Novartis Wins EU Backing For Meningitis B Vaccine (Reuters)
Parents Plead With Pfizer For Compassionate Use For Their Son (KARE)
Impax Fails To Win FDA Approval For Parkinson’s Drug (Bloomberg News)
Compounder Linked To Meningtis Paid Millions In Salaries (Reuters)
China Plans To Fast-Track High-Priority Generics (Pharma Times)
Hearing On Bayer Appeal Of Nexavar License To Begin (PharmaBiz)
Ireland Grapples With Generic Substitution (Irish Times)
EU Approves Novo Nordisk Diabetes Drug (Pharma Times)
Novartis Wins CHMP Backing For Eye Disease Drug (Zenopa)
ADHD Rates Rise In California (Reuters)
J&J May Offer $2B Deal On Hip Implant Litigation (Bloomberg News)
India Gives 18 Months For Testing Unaproved Drugs (InPharma Technologist)
India’s Serum Institute To Undercut Rival Vaccine Makers (Bloomberg News)
Drugmakers Slash Prices By 20 Percent In Phillipines (Manila Bullet...

Source: Pharmalot - January 22, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Alcon Bayer Compassionate Care Compounding Pharmacies Compulsory Licensing Diabetes Hip Implants Impax Laboratories JJ Johnson & Johnson Meningitis Meningitis B New England Compounding Center Nexavar Novartis Source Type: blogs